| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.133 | 2.998 | 2.780 | 5.697 | 5.091 | 1.931 | 673 | 1.114 | 1.272 | 742 |
| Total Income - EUR | 2.133 | 2.998 | 2.780 | 5.697 | 5.091 | 1.931 | 673 | 1.114 | 1.373 | 742 |
| Total Expenses - EUR | 4.926 | 2.983 | 1.284 | 3.848 | 3.035 | 1.285 | 1.961 | 3.070 | 8.779 | 9.519 |
| Gross Profit/Loss - EUR | -2.793 | 15 | 1.496 | 1.850 | 2.056 | 646 | -1.288 | -1.955 | -7.405 | -8.777 |
| Net Profit/Loss - EUR | -2.858 | -75 | 1.412 | 1.678 | 1.903 | 588 | -1.309 | -1.989 | -7.405 | -8.777 |
| Employees | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Dotix Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.492 | 89 | 0 | 381 | 321 | 263 | 206 | 156 | 11.654 | 6.435 |
| Current Assets | 64 | 68 | 65 | 65 | 15 | 3 | 19 | 0 | 679 | -2.381 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 64 | 68 | 65 | 65 | 15 | 3 | 19 | 0 | 679 | -2.381 |
| Shareholders Funds | -8.999 | -8.982 | -7.418 | -5.601 | -3.589 | -2.933 | -4.177 | -6.179 | -13.565 | -22.266 |
| Social Capital | 45 | 45 | 44 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 10.555 | 9.139 | 7.483 | 6.047 | 3.925 | 3.199 | 4.402 | 6.335 | 25.899 | 26.320 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4932 - 4932" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Dotix Intermed Srl